ELLIPTIC LABORATORIES ASA (ELABS.OL) Stock Income Statement
OSL:ELABS - Euronext Oslo - NO0010722283 - Common Stock - Currency: NOK
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 93.56M | 68.32M | 52.06M | 54.60M | 30.21M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 121.43M | 116.31M | 92.83M | 64.17M | 37.73M | |||
| Selling, General, and Administrative Expenses | 87.36M | 84.56M | 69.15M | 56.29M | 40.36M | |||
| Operating Income | -27.87M | -47.98M | -40.77M | -9.58M | -7.52M | |||
| Interest Income/Expense | 987.00K | 3.37M | 4.29M | -1.70M | -4.56M | |||
| Other Income/Expense | N/A | -482.00K | -1.46M | -256.00K | -895.50K | |||
| Non Recurring Items | -1.26M | -1.76M | -1.36M | -1.56M | -2.58M | |||
| Income Before Taxes | -28.15M | -46.86M | -39.30M | -13.09M | -15.56M | |||
| Income Tax | -5.97M | -8.86M | -6.30M | -1.88M | -3.05M | |||
| Net Income | -22.17M | -38.00M | -33.00M | -11.21M | -12.51M | |||
| EBITDA | -8.57M | -31.76M | -29.45M | -1.26M | -2.08M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.21 | -0.36 | -0.32 | -0.11 | -0.14 | |||
| Non GAAP EPS | -0.21 | -0.36 | -0.32 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -23.70% | -55.62% | -63.38% | -20.54% | -41.40% | |||
| Operating Profit Margin | -29.79% | -70.23% | -78.31% | -17.54% | -24.88% | |||
All data in NOK